BETA-LACTAM COMPOUNDS, PROCESS FOR REPODUCING THE SAME AND SERUM CHOLESTEROL-LOWERING AGENTS CONTAINING THE SAME
申请人:Kotobuki Pharmaceutical Co., Ltd.
公开号:EP1362855A1
公开(公告)日:2003-11-19
The compounds have the following general formula (I):
[wherein: A1, A3 and A4 are hydrogen atom, halogen atom, alkyl group having one to five carbon atoms, alkoxy group having one to five carbon atoms, -COOR1, a following formula
(wherein: R1 is hydrogen atom or alkyl group having one to five carbon atoms) or a following formula
[wherein: R2 is -CH2OH group, -CH2OC(O)-R1 group or -CO2-R1 group; R3 is -OH group or-OC(O)-R1 group; R4 is -(CH2)kR5(CH2)1- (k and 1 are 0 or 1 more integer; k+1 is 10 or fewer integer); R5 means bond (single bond (-), -CH=CH-, -OCH2-, carbonyl group or -CH(OH)-.]. One of A1, A3 and A4 in formula (I) is must be the group in above mentioned formula (a). A2 is alkyl chain having one to five carbon atoms, alkoxy chain having one to five carbon atoms, alkenyl chain having one to five carbon atoms, hydroxyalkyl chain having one to five carbon atoms or carbonylalkyl chain having one to five carbon atoms. n, p, q or r are 0, 1 or 2.] or their pharmaceutical acceptable salts.
这些化合物具有以下通式(I):
其中A1、A3 和 A4 为氢原子、卤素原子、具有 1 至 5 个碳原子的烷基、具有 1 至 5 个碳原子的烷氧基、-COOR1、下式
(其中:R1 为氢原子或具有一至五个碳原子的烷基)或下式
其中R2是-CH2OH基团、-CH2OC(O)-R1基团或-CO2-R1基团;R3是-OH基团或-OC(O)-R1基团;R4是-(CH2)kR5(CH2)1-(k和1是0或1以上的整数;k+1是10或10以下的整数);R5指键(单键(-)、-CH=CH-、-OCH2-、羰基或-CH(OH)-)]。式 (I)中的 A1、A3 和 A4 必须有一个是上述式 (a) 中的基团。A2 是具有 1 至 5 个碳原子的烷基链、具有 1 至 5 个碳原子的烷氧基链、具有 1 至 5 个碳原子的烯基链、具有 1 至 5 个碳原子的羟基烷基链或具有 1 至 5 个碳原子的羰基烷基链。n、p、q 或 r 是 0、1 或 2]或它们的药物可接受盐。